Pharmabiz

IPC to conduct workshops for public drug testing labs to test contamination in cough syrups

IPC to conduct workshops for public drug testing labs to test contamination in cough syrups: Shardul Nautiyal, Mumbai Thursday, October 23, 2025, 08:00 Hrs [IST] In the backdrop o ...
Pharmabiz

CDSCO releases draft guidance on Medical Devices Software

The Central Drugs Standard Control Organisation (CDSCO) has released a draft guidance document on Medical Devices Software, under the Medical Devices Rules (MDR), 2017, to bring in specific regulatory ...
Pharmabiz

Karnataka to convert State TB Control Institute to Pulmonology & General Medicine Unit under NUHM

Karnataka to convert State TB Control Institute to Pulmonology & General Medicine Unit under NUHM: Nandita Vijayasimha, Bengaluru Thursday, October 23, 2025, 08:00 Hrs [IST] Karna ...
Pharmabiz

Jharkhand JDC proposes unified health authority, higher GDP spending

Jharkhand JDC proposes unified health authority, higher GDP spending: Peethaambaran Kunnathoor, Chennai Thursday, October 23, 2025, 08:00 Hrs [IST] In a significant push for trans ...
Pharmabiz

Health ministry withdraws advertisement for filling up the post of DCGI

Health ministry withdraws advertisement for filling up the post of DCGI: Gireesh Babu, New Delhi Thursday, October 23, 2025, 08:00 Hrs [IST] The Union ministry of health and famil ...
Pharmabiz

Strides Pharma and Incepta Pharma partner to expand women’s health access with WHO-prequalified contraceptive

Strides Pharma and Incepta Pharma partner to expand women’s health access with WHO-prequalified contraceptive: Our Bureau, Bengaluru Thursday, October 23, 2025, 15:45 Hrs [IST] ...
Pharmabiz

Boehringer Ingelheim’s Jascayd approved in China to treat idiopathic pulmonary fibrosis

Boehringer Ingelheim’s Jascayd approved in China to treat idiopathic pulmonary fibrosis: Ingelheim, Germany Thursday, October 23, 2025, 12:00 Hrs [IST] Boehringer Ingelheim’s ...
Pharmabiz

Novartis Cosentyx meets primary and all secondary endpoints in phase III trial in patients with polymyalgia rheumatica

Novartis Cosentyx meets primary and all secondary endpoints in phase III trial in patients with polymyalgia rheumatica: Basel Thursday, October 23, 2025, 09:00 Hrs [IST] Novartis ...
Pharmabiz

Telangana govt & RMIT University, Melbourne, ink strategic pact to strengthen life sciences education and research

Telangana govt & RMIT University, Melbourne, ink strategic pact to strengthen life sciences education and research: Our Bureau, Bengaluru Thursday, October 23, 2025, 14:45 Hrs [IS ...
Pharmabiz

Merck presents findings from systematic review of 15 studies on epidemiology and AMR of pneumococcal serotypes covered by Capvaxive in US adults

As of 2023, the ABC data indicated that in older adults (=65 years), the prevalence of invasive PD attributed to Capvaxive-unique serotypes was more than triple (34.8%) that of PCV20-unique serotypes ...
Pharmabiz

Biocon Biologics gets Health Canada nod for Yesintek and Yesintek IV, a biosimilar to Stelara

Biocon Biologics gets Health Canada nod for Yesintek and Yesintek IV, a biosimilar to Stelara: Our Bureau, Bengaluru Thursday, October 23, 2025, 14:30 Hrs [IST] Biocon Biologics L ...